EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor

• (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate,hydrogen-donor:oxygen oxidoreductase inhibitor
• (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate,hydrogen-donor:oxygen oxidoreductase inhibitors
• (PG)H synthase inhibitor
• (PG)H synthase inhibitors
• COX inhibitor
• EC 1.14.99.1 (cyclooxygenase) inhibitor
• EC 1.14.99.1 (cyclooxygenase) inhibitors
• EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitors
• EC 1.14.99.1 inhibitor
• EC 1.14.99.1 inhibitors
• PG synthetase inhibitor
• PG synthetase inhibitors
• cyclooxygenase (EC 1.14.99.1) inhibitor
• cyclooxygenase (EC 1.14.99.1) inhibitors
• cyclooxygenase inhibitor
• cyclooxygenase inhibitors
• fatty acid cyclooxygenase inhibitor
• fatty acid cyclooxygenase inhibitors
• prostaglandin G/H synthase inhibitor
• prostaglandin G/H synthase inhibitors
• prostaglandin endoperoxide synthetase inhibitor
• prostaglandin endoperoxide synthetase inhibitors
• prostaglandin synthase inhibitor
• prostaglandin synthase inhibitors
• prostaglandin synthetase inhibitor
• prostaglandin synthetase inhibitors

• EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor